The trading price of Fulgent Genetics, Inc. (NASDAQ:FLGT) floating lower at last check on Wednesday, Apr 07, closing at $93.07, -7.83% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $84.19 and $92.01. The company’s P/E ratio in the trailing 12-month period was 11.08, while its 5Y monthly beta was 1.62. In examining the 52-week price action we see that the stock hit a 52-week high of $189.89 and a 52-week low of $8.90 -. Over the past month, the stock has gained 0.79% in value.
Fulgent Genetics, Inc., whose market valuation is $2.58 Billion at the time of this writing, is expected to release its quarterly earnings report in May 2021. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by $5.98 per share this quarter, however they have predicted annual earnings per share of $12.46 for 2021 and $3.62 for 2022. It means analysts are expecting annual earnings per share growth of 0.37% this year and -0.71% next year.
On the technical side, indicators suggest FLGT has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned FLGT a recommendation rating is 4. Out of them, 1 rate it a Hold, while 2 recommend Buy, whereas none assign an Outperform rating. None analyst(s) have tagged Fulgent Genetics, Inc. (FLGT) as Underperform, while 1 advise Sell. Analysts have rated the stock Hold, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 0, which symbolizes a positive outlook. A quick review shows that FLGT’s price is currently -16.16% off the SMA20 and -23.95% off the SMA50. The RSI metric on the 14-day chart is currently showing 40.51, and weekly volatility stands at 7.32%. When measured over the past 30 days, the indicator reaches 11.65%. Fulgent Genetics, Inc. (NASDAQ:FLGT)’s beta value is currently sitting at 1.62, while the Average True Range indicator is currently displaying 11.49. With analysts defining $55-$140 as the low and high price targets, we arrive at a consensus price target of $107 for the trailing 12-month period. The current price is about -35.88% off the estimated low and 63.21% off the forecast high, based on this estimate. Investors will be thrilled if FLGT’s share price rises to $126, which is the median consensus price. At that level, FLGT’s share price would be +46.89% above current price.
To see how Fulgent Genetics, Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: FLGT stock’s performance was -7.83% at last check in today’s session, and +875.58% in the past year, while Cerner Corp (CERN) has been trading +0.08% in recent session and positioned +15.93% higher than it was a year ago. Another comparable company 10X Genomics Inc (TXG) saw its stock trading -6.38% lower in today’s session but was up +236.07% in a year. Furthermore, Syneos Health Inc (SYNH) showed a decline of -7.83% today while its price kept rising at 875.58% over the past year. Fulgent Genetics, Inc. has a P/E ratio of 11.08, compared to Cerner Corp’s 28.59 and 10X Genomics Inc’s 0. Also during today’s trading, the S&P 500 Index has surged 0.16%, while the Dow Jones Industrial also saw a positive session, up +0.01% today.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
An evaluation of the daily trading volume of Fulgent Genetics, Inc. (NASDAQ:FLGT) indicates that the 3-month average is 2.09 Million. However, this figure has declined over the past 10 days to an average of 1.44 Million.
Currently, records show that 28.99 Million of the company’s shares remain outstanding. According to Thomson Reuters data, insiders hold 34.22% of outstanding shares, whereas institutions hold 34.6%. The stats also highlight that short interest as of March 14, 2021, stood at 4.58 Million shares, resulting in a short ratio of 2.15 at that time. From this, we can conclude that short interest is 15.88% of the company’s total outstanding shares. It is noteworthy that short shares in March were up slightly from the previous month’s figure, which was 2.89 Million. However, since the stock’s price has seen +78.64% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.